Ruijiming Biological lands tens of millions in new round led by Chuchang Fund

What's the deal? Ruijiming BiologicalDealroom has a profile for this one. Try Dealroom →, a Shandong-based biotech company, announced on 11 August 2026 that it had closed a new funding round worth tens of millions of Chinese yuan. The round was backed by Chuchang FundDealroom has a profile for this one. Try Dealroom →, with Junying CapitalDealroom has a profile for this one. Try Dealroom → serving as investment adviser.

Who's backing it? Chuchang Fund is the sole wholly owned private-equity investment platform of the founder of JointownDealroom has a profile for this one. Try Dealroom →, one of China's major pharmaceutical distributors.

The signal: Backing from an established pharmaceutical distributor's investment arm points to continued strategic interest in China's biotech sector, where industry insiders remain active in funding early-stage companies.

Image credit: Generated with Gemini

Read more: Jiemian News